Stockscreener 앱 받기
4.98
0.00%
0.00
시간 외 거래:
4.97
-0.01
-0.20%
전일 마감가:
$4.98
열려 있는:
$5.01
하루 거래량:
62,424
Relative Volume:
0.01
시가총액:
$15.90M
수익:
-
순이익/손실:
$-37.75M
주가수익비율:
-1.5323
EPS:
-3.25
순현금흐름:
$-30.91M
1주 성능:
+2.26%
1개월 성능:
+2.26%
6개월 성능:
+1,540%
1년 성능:
+137.14%
1일 변동 폭
$4.76
$5.13
1주일 범위
$4.60
$5.13
52주 변동 폭
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
명칭
Cellectar Biosciences Inc
전화
(608) 441-8120
주소
100 CAMPUS DRIVE, FLORHAM PARK, NJ
CLRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
4.98 | 15.90M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 재개 | Ladenburg Thalmann | Buy |
| 2020-07-01 | 개시 | Oppenheimer | Outperform |
| 2020-01-21 | 재개 | ROTH Capital | Buy |
| 2019-09-13 | 개시 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc 주식(CLRB)의 최신 뉴스
Traders Consider Averaging Down in Cellectar Biosciences Inc.Quarterly Portfolio Report & Accurate Intraday Trade Tips - beatles.ru
Is it time to cut losses on Cellectar Biosciences Inc.2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Building trade automation scripts for Cellectar Biosciences Inc.July 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Regression analysis insights on Cellectar Biosciences Inc. performanceCPI Data & AI Based Buy/Sell Signal Reports - Newser
Market Leaders: What drives Cellectar Biosciences Inc.’s stock price2025 Pullback Review & Accurate Buy Signal Alerts - خودرو بانک
Using fundamentals and technicals on Cellectar Biosciences Inc.Exit Point & Verified Short-Term Trading Plans - Newser
Chart overlay techniques for tracking Cellectar Biosciences Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - Newser
Statistical indicators supporting Cellectar Biosciences Inc.’s strength2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Should you hold or exit Cellectar Biosciences Inc. nowJuly 2025 Outlook & Daily Growth Stock Investment Tips - Newser
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September - GlobeNewswire
Does Cellectar Biosciences Inc. show high probability of reboundJuly 2025 Levels & Precise Buy Zone Identification - Newser
Cellectar Biosciences, Inc. Announces Participation in Key Cancer Research Conferences and Panel Discussions This September - Quiver Quantitative
Cellectar Biosciences to Present at Multiple Medical Meetings and Industry Conferences in September. - AInvest
Breakthrough Cancer Treatment Updates: Cellectar to Share Pediatric Brain Tumor Trial Data at Key September Events - Stock Titan
Identifying reversal signals in Cellectar Biosciences Inc.2025 Technical Overview & Safe Capital Growth Tips - Newser
Using AI based signals to follow Cellectar Biosciences Inc.Treasury Yields & Stepwise Trade Signal Guides - Newser
Can Cellectar Biosciences Inc. expand its profit marginsPortfolio Return Report & AI Optimized Trading Strategy Guides - خودرو بانک
How does Cellectar Biosciences Inc. compare to its peers2025 AllTime Highs & Reliable Volume Spike Trade Alerts - خودرو بانک
Will Cellectar Biosciences Inc. see short term momentumOptions Play & Advanced Swing Trade Entry Plans - Newser
Is Cellectar Biosciences Inc. a strong candidate for buy and hold - خودرو بانک
Real time social sentiment graph for Cellectar Biosciences Inc.2025 Institutional Moves & Community Consensus Picks - Newser
How to use a screener to detect Cellectar Biosciences Inc. breakouts2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
How moving averages guide Cellectar Biosciences Inc. trading2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Measuring Cellectar Biosciences Inc.’s beta against major indices2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Cellectar Biosciences shares fall 1.24% premarket as Oncolytics Biotech Inc. gains FDA approval for breakthrough therapies. - AInvest
Cellectar Biosciences Announces Poster Presentation at AACR Conference on Preclinical Data for Novel Cancer Treatment CLR 121225 - Quiver Quantitative
Cellectar Biosciences Presents Data on CLR 121225 in Poster Presentation at AACR Special Conference on Pancreatic Cancer Research - AInvest
Cellectar Biosciences to Present Data in Poster - GlobeNewswire
Novel Pancreatic Cancer Radio-Conjugate: Cellectar to Present Breakthrough Treatment Data at AACR Conference - Stock Titan
Analyzing drawdowns of Cellectar Biosciences Inc. with statistical toolsJuly 2025 Levels & Reliable Momentum Entry Alerts - Newser
What indicators show strength in Cellectar Biosciences Inc.2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
How to use Fibonacci retracement on Cellectar Biosciences Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Aug Macro: How does Cellectar Biosciences Inc. compare to its peersPortfolio Growth Summary & Weekly Chart Analysis and Guides - خودرو بانک
Cellectar Biosciences Inc. stock momentum explainedQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
What is Cellectar Biosciences Inc. s revenue forecast2025 Trading Volume Trends & Fast Moving Stock Trade Plans - خودرو بانک
Why Cellectar Biosciences Inc. stock attracts strong analyst attentionTrade Ideas & Real-Time Price Movement Reports - Newser
Is Cellectar Biosciences Inc. trending in predictive chart modelsEarnings Beat & Weekly High Conviction Trade Ideas - Newser
Cellectar Biosciences shares rise 1.87% after-hours due to FDA approval of breakthrough cancer therapies. - AInvest
Cellectar Biosciences shares fall 1.45% after-hours as Oncolytics Biotech Inc. gains regulatory momentum. - AInvest
Is Cellectar Biosciences Inc. vulnerable to short sellers2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - The Ritz Herald
Is Cellectar Biosciences Inc. part of any ETF2025 Support & Resistance & Technical Pattern Recognition Alerts - خودرو بانک
Earnings Recap: Is Cellectar Biosciences Inc. vulnerable to short sellersRate Hike & Target Return Focused Stock Picks - خودرو بانک
Will Cellectar Biosciences Inc. outperform during market ralliesEarnings Recap Summary & Community Trade Idea Sharing Platform - خودرو بانک
Is Cellectar Biosciences Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - خودرو بانک
What is Cellectar Biosciences Inc. s debt to equity ratioQuarterly Market Review & AI Enhanced Trading Signals - خودرو بانک
Cellectar Biosciences Inc (CLRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):